trial · primary record
RXIM002
Immune Thrombocytopenia (ITP)
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 27 |
| Primary completion | 2029-12-31 |
| Primary endpoint | Incidence of treatment-emergent adverse events |
| Registry ID | NCT07765966 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:55.973Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07765966
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.